Literature DB >> 3876447

Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic lupus erythematosus.

C A Penning, M A French, N R Rowell, P Hughes.   

Abstract

Sera from 35 patients with systemic lupus erythematosus were examined for a cytotoxic effect on human umbilical vein endothelium. Although none of these sera produced direct cytotoxicity of 51Cr-labelled endothelial cells, even with added complement, 3 sera regularly produced increased 51Cr release when co-cultured with endothelial cells and normal human peripheral blood mononuclear cells. The effector cells involved in this cytotoxicity possessed Fc-receptors but were non-T and non-adherent while fractionation studies indicated that the responsible serum factor(s) was IgG, probably in the form of immune complexes of small size. Control studies, using sera from both 27 normal controls and 19 patients with either diabetes or extensive atherosclerotic vascular disease failed to reveal any similar cytotoxicity. Two of the 3 patients, whose sera produced this antibody-dependent cellular cytotoxicity, had had clinical episodes of major vascular thrombosis, raising the possibility that the cytotoxicity might provide an additional pathogenic mechanism in certain patients with systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876447

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  12 in total

Review 1.  Anti-endothelial cell antibodies in systemic sclerosis.

Authors:  Y Renaudineau; R Revelen; Y Levy; K Salojin; B Gilburg; Y Shoenfeld; P Youinou
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies.

Authors:  C O Savage; B E Pottinger; G Gaskin; C M Lockwood; C D Pusey; J D Pearson
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 3.  Antiendothelial cell antibodies (AECA) in systemic lupus erythematosus (SLE).

Authors:  D D'Cruz; M Khamashta; G Hughes
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

4.  IgG and IgM anti-endothelial cell antibodies in patients with collagen-vascular disorders.

Authors:  N P Quadros; P J Roberts-Thomson; A S Gallus
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 5.  The antiphospholipid antibody dilemma.

Authors:  R H Derksen; P Hasselaar; J D Oosting; P G De Groot
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

6.  Circulating intercellular adhesion molecules-1 and autoantibodies including anti-endothelial cell, anti-cardiolipin, and anti-neutrophil cytoplasma antibodies in patients with vasculitis.

Authors:  C R Wang; M F Liu; R T Tsai; C Y Chuang; C Y Chen
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

Review 7.  Anti-endothelial cell antibodies and autoimmune diseases.

Authors:  N Del Papa; D Gambini; P L Meroni
Journal:  Clin Rev Allergy       Date:  1994

8.  Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC?

Authors:  B E Ballieux; K T Zondervan; P Kievit; E C Hagen; L A van Es; F J van der Woude; M R Daha
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

9.  Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells.

Authors:  W J Mayet; A Schwarting; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

10.  Serum immunoglobulin G reactive with endothelial cells in inflammatory bowel disease.

Authors:  A M Sawyerr; B E Pottinger; C O Savage; N J Bradley; M Hudson; A J Wakefield; J D Pearson; R E Pounder
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.